Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A for Diabetic Neuropathic Pain
NCT02460107Phase 1Terminated
- Sponsor
- Catholic University of Korea St. Paul's Hospital
- Start
- May 2015
- Primary completion
- Nov 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of botulinum toxin type A in peripheral polyneuropathy (3 arms), sponsored by Catholic University of Korea St. Paul's Hospital. Primary endpoint: Pain intensity using numeric rating scale at 4 weeks. Started May 2015; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
peripheral polyneuropathy
Beyond the preview
Go deeper on NCT02460107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02460107.